Podchaser Logo
Home
Consolidation Immunotherapy After Concurrent CRT: What Do Real-World Data Show?

Consolidation Immunotherapy After Concurrent CRT: What Do Real-World Data Show?

Released Wednesday, 15th May 2024
Good episode? Give it some love!
Consolidation Immunotherapy After Concurrent CRT: What Do Real-World Data Show?

Consolidation Immunotherapy After Concurrent CRT: What Do Real-World Data Show?

Consolidation Immunotherapy After Concurrent CRT: What Do Real-World Data Show?

Consolidation Immunotherapy After Concurrent CRT: What Do Real-World Data Show?

Wednesday, 15th May 2024
Good episode? Give it some love!
Rate Episode

CME credits: 1.00
Valid until: 15-05-2025
Claim your CME credit at https://reachmd.com/programs/cme/consolidation-immunotherapy-after-concurrent-crt-what-do-real-world-data-show/24387/

In this video series, learners will explore best practices for the use of immunotherapies in unresectable stage III NSCLC, including staging, determining resectability, applying clinical data, and managing toxicities.

Show More

Unlock more with Podchaser Pro

  • Audience Insights
  • Contact Information
  • Demographics
  • Charts
  • Sponsor History
  • and More!
Pro Features